Attenuated TGF-β1 responsiveness of dendritic cells and their precursors in atopic dermatitis (Q43848397)

27 November 2017

Attenuated TGF-β1 responsiveness of dendritic cells and their precursors in atopic dermatitis (English)

1 reference

27 November 2017

1 reference

Wen-Ming Peng

1

1 reference

27 November 2017

Laura Maintz

series ordinal

2

1 reference

27 November 2017

Jean-Pierre Allam

series ordinal

3

1 reference

27 November 2017

Natalija Novak

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

9 April 2013

1 reference

European Journal of Immunology

27 November 2017

1 reference

27 November 2017

43

1 reference

27 November 2017

5

1 reference

27 November 2017

1374-1382

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

27 November 2017

1 reference

Pathogenesis of atopic dermatitis: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Smads: transcriptional activators of TGF-beta responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Transforming growth factor beta: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Insights into Langerhans cell function from Langerhans cell ablation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Cutaneous dendritic cells in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Tacrolimus and TGF-beta act synergistically on the generation of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Langerhans cells--revisiting the paradigm using genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

TGF-beta suppresses IFN-gamma-STAT1-dependent gene transcription by enhancing STAT1-PIAS1 interactions in epithelia but not monocytes/macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Control of Smad7 stability by competition between acetylation and ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Melanoma arising in burn scars: report of 3 observations and a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Smad3 signal transducer regulates skin inflammation and specific IgE response in murine model of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Alterations of TGF-beta/Smad mRNA expression in atopic dermatitis following narrow-band ultraviolet B phototherapy: results of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Integration of Smad and MAPK pathways: a link and a linker revisited

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Regulation of Smad signaling by protein kinase C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Spontaneous expression of mRNA for IL-10, GM-CSF, TGF-beta, TGF-alpha, and IL-6 in peripheral blood mononuclear cells from atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Diagnostic criteria for atopic dermatitis: consider the context

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242955

7 January 2021

Identifiers

DOI

10.1002/EJI.201242955

1 reference

27 November 2017

1 reference